Epiphany Capital

About The Fund

Epiphany Capital is a venture capital firm that specializes in investments across various growth stages including Seed, Secondary Market, Late Stage Venture, and Early Stage Venture. This investment fund, based in Manchester, United Kingdom, diligently works with high growth companies operating primarily within the tech and healthcare sectors. With a clear focus on innovation and development, they target businesses that demonstrate strong potential in BioTech and Productivity industries. Epiphany Capital is known for its keen interest in companies that are poised for transformative growth or are already showing significant traction within their respective markets. Although the fund maintains flexibility, their investment amounts are characteristically uniform, with a minimum and maximum investment of approximately $3,440,000. This financial commitment reflects their dedication to fostering substantial and strategic growth periods for their portfolio companies. By leveraging their industry expertise and financial resources, Epiphany Capital aims to guide and drive their investees towards achieving substantial market impacts and delivering long-term value not only to their stakeholders but also to the wider community and sectors they operate within. They stand out for their willingness to engage with ventures at critical junctures of development—whether these be early ventures in need of seed capital to prove their concepts or more established firms looking to scale operations through larger, strategic investments in the secondary market or late stages.